explore -WSS

explore

author：hotspot 2025-09-28 02:31:31 - browse：99853

Blue CAR-T cell attacks a leukemia cell. --health coverage from STAT — Engineered receptors on the surface of a T-lymphocyte bind to a leukemia cell. Adobe

The announcement on Tuesday that the Food and Drug Administration was investigating whether CAR-T immunotherapy had itself caused blood cancers initially appeared to be a significant blow to one of the brightest spots in cancer care.

But experts quickly cautioned that risk of this complication is probably minuscule compared to the known risk of secondary cancers from other cancer therapies like chemotherapy and radiation. They noted that CAR-T cells are immune cells that are genetically engineered to fight cancer, and that such genetic modifications were long thought to carry a risk of causing a second, new cancer in patients. The surprise, in a way, is that since CAR-T was first invented more than 10 years ago, that risk had remained just theoretical.

“There’s been a requirement for long-term follow up. I think this is why we’re all surprised. As far as I think any one of us knew, it’d never happened with any of the FDA-approved CAR-Ts,” said Marcela Maus, a cell therapy researcher at Mass General Cancer Center.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Why scientists need input from humanists on sensitive research

WSS

The United States must get value

Abbott's new stent may help patients with peripheral artery disease

FDA advisers back CAR

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

EPA limits use of carcinogenic gas for sterilizing medical devices

What a koala virus tells us about the human genome

focus

explore

hotspot

Hollywood unions extend contract negotiations for actors

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

Jerome Adams on the need for new antivirals for Covid

The White House hikes tariffs on plastic syringes made in China

Peter Hotez and the public health issue of online harassment

FDA advisers back CAR

Peter Hotez and the public health issue of online harassment

Novo Nordisk testing Wegovy against alcohol

Trump demands the U.S. pay no more for drugs than other countries … again

STAT series 'Denied by AI' wins major journalism prizes

focus

Male and female sex labels in research insufficient, scientists say

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

Novo Nordisk testing Wegovy against alcohol

Boston's new lab space is opening empty

Lilly’s weekly insulin works as well as daily products, new studies show

WuXi Biologics execs register to lobby as Congress comes for the company

explore

Wikipedia

hotspot

hotspot